Arthur Reshad Garan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 93 | 2023 | 1194 | 9.790 |
Why?
|
Shock, Cardiogenic | 53 | 2024 | 688 | 8.150 |
Why?
|
Extracorporeal Membrane Oxygenation | 37 | 2023 | 1354 | 4.960 |
Why?
|
Heart Failure | 92 | 2023 | 10900 | 4.470 |
Why?
|
Heart Transplantation | 36 | 2023 | 3110 | 2.350 |
Why?
|
Hemodynamics | 18 | 2021 | 4199 | 2.200 |
Why?
|
Myocardial Infarction | 23 | 2024 | 11727 | 2.040 |
Why?
|
Intra-Aortic Balloon Pumping | 8 | 2022 | 219 | 1.970 |
Why?
|
Heart Ventricles | 15 | 2022 | 3821 | 1.270 |
Why?
|
Defibrillators, Implantable | 5 | 2017 | 1440 | 1.210 |
Why?
|
Ventricular Fibrillation | 4 | 2019 | 538 | 0.990 |
Why?
|
Hospital Mortality | 30 | 2023 | 5317 | 0.970 |
Why?
|
Ventricular Function, Left | 18 | 2023 | 3670 | 0.950 |
Why?
|
Cardiac Output | 2 | 2019 | 854 | 0.870 |
Why?
|
Registries | 18 | 2023 | 8089 | 0.870 |
Why?
|
Tachycardia, Ventricular | 6 | 2020 | 1273 | 0.860 |
Why?
|
Primary Graft Dysfunction | 5 | 2019 | 93 | 0.730 |
Why?
|
Retrospective Studies | 87 | 2024 | 77449 | 0.720 |
Why?
|
Waiting Lists | 8 | 2020 | 692 | 0.670 |
Why?
|
Ventricular Function, Right | 8 | 2021 | 591 | 0.660 |
Why?
|
Prosthesis Implantation | 6 | 2020 | 642 | 0.590 |
Why?
|
Thrombosis | 12 | 2021 | 2968 | 0.580 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 514 | 0.540 |
Why?
|
Myocarditis | 1 | 2023 | 771 | 0.530 |
Why?
|
Hospices | 1 | 2018 | 265 | 0.510 |
Why?
|
Middle Aged | 98 | 2023 | 213383 | 0.510 |
Why?
|
Treatment Outcome | 51 | 2023 | 63114 | 0.510 |
Why?
|
Propensity Score | 3 | 2019 | 1781 | 0.470 |
Why?
|
Ventricular Dysfunction, Right | 5 | 2021 | 581 | 0.460 |
Why?
|
Male | 110 | 2023 | 350118 | 0.460 |
Why?
|
Humans | 150 | 2024 | 744343 | 0.460 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2018 | 2073 | 0.440 |
Why?
|
Survival Rate | 20 | 2020 | 12788 | 0.440 |
Why?
|
New York | 7 | 2017 | 886 | 0.400 |
Why?
|
Aged | 64 | 2023 | 163280 | 0.390 |
Why?
|
Female | 100 | 2023 | 380194 | 0.390 |
Why?
|
Vascular Resistance | 2 | 2015 | 936 | 0.390 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2024 | 980 | 0.380 |
Why?
|
Disease Management | 2 | 2020 | 2459 | 0.370 |
Why?
|
Tricuspid Valve | 3 | 2018 | 403 | 0.360 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.360 |
Why?
|
Catheter Ablation | 4 | 2020 | 2758 | 0.350 |
Why?
|
Time Factors | 24 | 2020 | 40075 | 0.350 |
Why?
|
Prosthesis Design | 8 | 2019 | 2110 | 0.320 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2024 | 339 | 0.320 |
Why?
|
Assisted Circulation | 2 | 2019 | 103 | 0.320 |
Why?
|
Pulmonary Artery | 4 | 2023 | 1912 | 0.310 |
Why?
|
Shock | 2 | 2022 | 318 | 0.300 |
Why?
|
Stroke Volume | 5 | 2023 | 5007 | 0.270 |
Why?
|
Risk Factors | 31 | 2023 | 72290 | 0.270 |
Why?
|
Follow-Up Studies | 16 | 2020 | 39050 | 0.260 |
Why?
|
Primary Prevention | 1 | 2013 | 1167 | 0.260 |
Why?
|
Streptomycin | 1 | 2005 | 69 | 0.260 |
Why?
|
Postoperative Complications | 11 | 2020 | 15295 | 0.260 |
Why?
|
Creatinine | 2 | 2022 | 1919 | 0.260 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2019 | 488 | 0.260 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2005 | 192 | 0.250 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2018 | 349 | 0.250 |
Why?
|
Adult | 49 | 2024 | 214055 | 0.250 |
Why?
|
Lactates | 2 | 2023 | 432 | 0.250 |
Why?
|
Incidence | 15 | 2022 | 20947 | 0.240 |
Why?
|
Antiporters | 1 | 2005 | 277 | 0.230 |
Why?
|
Heart Injuries | 1 | 2005 | 210 | 0.220 |
Why?
|
Atrial Fibrillation | 4 | 2022 | 5034 | 0.220 |
Why?
|
Thoracic Injuries | 1 | 2005 | 272 | 0.210 |
Why?
|
Glomerular Filtration Rate | 3 | 2020 | 2170 | 0.210 |
Why?
|
Reoperation | 4 | 2019 | 4201 | 0.200 |
Why?
|
Heart Arrest | 2 | 2022 | 1470 | 0.200 |
Why?
|
Catheters | 2 | 2023 | 425 | 0.200 |
Why?
|
Recovery of Function | 7 | 2019 | 2925 | 0.190 |
Why?
|
Cryosurgery | 1 | 2006 | 453 | 0.190 |
Why?
|
Prosthesis-Related Infections | 2 | 2018 | 538 | 0.190 |
Why?
|
Sternotomy | 2 | 2018 | 121 | 0.190 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2017 | 531 | 0.180 |
Why?
|
New York City | 6 | 2019 | 710 | 0.180 |
Why?
|
Heart-Lung Transplantation | 1 | 2020 | 71 | 0.180 |
Why?
|
Palliative Care | 4 | 2019 | 3493 | 0.180 |
Why?
|
Pulmonary Veins | 1 | 2006 | 761 | 0.180 |
Why?
|
Cause of Death | 3 | 2019 | 3584 | 0.180 |
Why?
|
Axillary Artery | 1 | 2019 | 50 | 0.170 |
Why?
|
Advanced Cardiac Life Support | 1 | 2019 | 70 | 0.170 |
Why?
|
Cystatin C | 1 | 2020 | 250 | 0.160 |
Why?
|
Endotoxemia | 1 | 2020 | 207 | 0.160 |
Why?
|
Oxygenators | 1 | 2018 | 34 | 0.160 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 146 | 0.160 |
Why?
|
Blood Group Antigens | 1 | 2020 | 180 | 0.160 |
Why?
|
Hemolysis | 2 | 2019 | 420 | 0.160 |
Why?
|
Prognosis | 10 | 2022 | 29063 | 0.160 |
Why?
|
Echocardiography | 5 | 2020 | 5102 | 0.160 |
Why?
|
Cardiac Imaging Techniques | 1 | 2020 | 269 | 0.160 |
Why?
|
Exercise Tolerance | 2 | 2013 | 770 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 3 | 2019 | 3537 | 0.160 |
Why?
|
Graft Rejection | 2 | 2018 | 4397 | 0.160 |
Why?
|
Lymphocele | 1 | 2017 | 16 | 0.160 |
Why?
|
Oxygenators, Membrane | 1 | 2017 | 56 | 0.150 |
Why?
|
Adenosine Monophosphate | 1 | 2019 | 275 | 0.150 |
Why?
|
Glucosides | 1 | 2021 | 451 | 0.150 |
Why?
|
Risk Assessment | 10 | 2021 | 23338 | 0.150 |
Why?
|
Decompression, Surgical | 2 | 2019 | 594 | 0.150 |
Why?
|
International Normalized Ratio | 2 | 2016 | 367 | 0.150 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1130 | 0.150 |
Why?
|
Blood Pressure Determination | 2 | 2018 | 634 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 458 | 0.150 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1537 | 0.140 |
Why?
|
Death, Sudden, Cardiac | 1 | 2005 | 1541 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 8 | 2021 | 6538 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15165 | 0.140 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2016 | 424 | 0.140 |
Why?
|
Tacrolimus | 1 | 2020 | 743 | 0.140 |
Why?
|
Hemorrhage | 4 | 2021 | 3461 | 0.140 |
Why?
|
Pulsatile Flow | 1 | 2017 | 332 | 0.140 |
Why?
|
Device Removal | 2 | 2018 | 656 | 0.140 |
Why?
|
Survival Analysis | 5 | 2019 | 10252 | 0.140 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 367 | 0.140 |
Why?
|
Cardiotonic Agents | 1 | 2019 | 535 | 0.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 642 | 0.130 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2017 | 482 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 345 | 0.130 |
Why?
|
Propanolamines | 2 | 2013 | 167 | 0.130 |
Why?
|
Amiodarone | 1 | 2017 | 212 | 0.130 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2015 | 50 | 0.130 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 236 | 0.130 |
Why?
|
Social Class | 3 | 2023 | 1999 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2023 | 1041 | 0.130 |
Why?
|
Prothrombin Time | 1 | 2015 | 119 | 0.130 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 845 | 0.130 |
Why?
|
United States | 16 | 2022 | 69872 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1199 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1850 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 257 | 0.120 |
Why?
|
Anticoagulants | 4 | 2017 | 4599 | 0.120 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2015 | 124 | 0.120 |
Why?
|
Carbazoles | 2 | 2013 | 226 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 579 | 0.120 |
Why?
|
Stroke | 5 | 2021 | 9981 | 0.120 |
Why?
|
Proteinuria | 1 | 2016 | 658 | 0.120 |
Why?
|
Postoperative Care | 2 | 2017 | 1486 | 0.110 |
Why?
|
Lisinopril | 1 | 2013 | 54 | 0.110 |
Why?
|
Papillary Muscles | 1 | 2014 | 203 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2018 | 847 | 0.110 |
Why?
|
Milrinone | 1 | 2013 | 84 | 0.110 |
Why?
|
Cohort Studies | 10 | 2021 | 40561 | 0.110 |
Why?
|
Mitral Valve Insufficiency | 1 | 2022 | 1422 | 0.110 |
Why?
|
von Willebrand Diseases | 1 | 2014 | 127 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2759 | 0.110 |
Why?
|
Tissue Donors | 2 | 2021 | 2240 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2018 | 742 | 0.100 |
Why?
|
Prospective Studies | 8 | 2020 | 53288 | 0.100 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15540 | 0.100 |
Why?
|
Perioperative Care | 1 | 2019 | 1002 | 0.100 |
Why?
|
Patient Readmission | 3 | 2020 | 3114 | 0.100 |
Why?
|
Acute Disease | 2 | 2019 | 7149 | 0.100 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2017 | 868 | 0.100 |
Why?
|
Cardiology | 2 | 2020 | 1668 | 0.100 |
Why?
|
Physical Endurance | 1 | 2013 | 370 | 0.100 |
Why?
|
Electrophysiology | 1 | 2014 | 1308 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2017 | 1082 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2376 | 0.100 |
Why?
|
Warfarin | 2 | 2016 | 1496 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2016 | 804 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1518 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1534 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 498 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 896 | 0.090 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.090 |
Why?
|
Heparin | 1 | 2017 | 1637 | 0.090 |
Why?
|
Self Care | 1 | 2015 | 786 | 0.090 |
Why?
|
Blood Pressure | 3 | 2017 | 8554 | 0.090 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1179 | 0.090 |
Why?
|
Medicare | 4 | 2022 | 6566 | 0.090 |
Why?
|
Catheterization | 2 | 2023 | 1470 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3086 | 0.080 |
Why?
|
Cerebrovascular Circulation | 1 | 2019 | 2731 | 0.080 |
Why?
|
Patient Selection | 5 | 2020 | 4215 | 0.080 |
Why?
|
Heart Conduction System | 1 | 2014 | 1047 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2016 | 1873 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2020 | 1912 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1922 | 0.080 |
Why?
|
Obesity | 3 | 2020 | 12745 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 851 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2569 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2018 | 2708 | 0.080 |
Why?
|
Income | 1 | 2016 | 1913 | 0.080 |
Why?
|
Hypertension | 2 | 2018 | 8480 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.070 |
Why?
|
Amyloidosis | 1 | 2014 | 795 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 3068 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1177 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2023 | 4468 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1240 | 0.070 |
Why?
|
Thoracic Surgical Procedures | 2 | 2020 | 342 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1694 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2019 | 3679 | 0.070 |
Why?
|
Heart Rate | 2 | 2019 | 4091 | 0.070 |
Why?
|
Comorbidity | 5 | 2019 | 10388 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.070 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1536 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2017 | 1972 | 0.060 |
Why?
|
Ventricular Pressure | 1 | 2005 | 199 | 0.060 |
Why?
|
Primary Health Care | 1 | 2020 | 4558 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18370 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5751 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Preoperative Period | 2 | 2016 | 549 | 0.060 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5391 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57776 | 0.060 |
Why?
|
Equipment Failure | 2 | 2016 | 578 | 0.060 |
Why?
|
Sheep | 1 | 2006 | 1437 | 0.060 |
Why?
|
Postoperative Period | 2 | 2020 | 1842 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9146 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 12354 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
Disease Progression | 4 | 2023 | 13284 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2023 | 4577 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7186 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7474 | 0.050 |
Why?
|
Algorithms | 3 | 2019 | 13881 | 0.050 |
Why?
|
Myocardium | 2 | 2015 | 4776 | 0.050 |
Why?
|
Translating | 1 | 2022 | 144 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2788 | 0.050 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2021 | 264 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.050 |
Why?
|
Random Allocation | 1 | 2005 | 2429 | 0.050 |
Why?
|
Heart | 1 | 2013 | 4467 | 0.050 |
Why?
|
Odds Ratio | 3 | 2018 | 9849 | 0.040 |
Why?
|
Blood Volume | 1 | 2021 | 565 | 0.040 |
Why?
|
Prevalence | 4 | 2018 | 15226 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
Denmark | 1 | 2021 | 738 | 0.040 |
Why?
|
Communication Barriers | 1 | 2022 | 398 | 0.040 |
Why?
|
Wounds, Nonpenetrating | 1 | 2005 | 794 | 0.040 |
Why?
|
Equipment Design | 2 | 2017 | 3582 | 0.040 |
Why?
|
Databases, Factual | 3 | 2020 | 7729 | 0.040 |
Why?
|
Adolescent | 4 | 2023 | 85781 | 0.040 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2018 | 107 | 0.040 |
Why?
|
Prosthesis Failure | 2 | 2014 | 1206 | 0.040 |
Why?
|
Markov Chains | 1 | 2021 | 969 | 0.040 |
Why?
|
Taiwan | 1 | 2019 | 496 | 0.040 |
Why?
|
Biopsy | 1 | 2009 | 6756 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2022 | 1184 | 0.040 |
Why?
|
Groin | 1 | 2017 | 104 | 0.040 |
Why?
|
Urofollitropin | 1 | 2016 | 2 | 0.040 |
Why?
|
Electrocardiography | 2 | 2014 | 6442 | 0.040 |
Why?
|
Graft Survival | 2 | 2018 | 3737 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5137 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 56430 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18029 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2013 | 1869 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19905 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.030 |
Why?
|
Resuscitation Orders | 1 | 2018 | 269 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15076 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8340 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2019 | 1423 | 0.030 |
Why?
|
Xiphoid Bone | 1 | 2014 | 10 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2016 | 364 | 0.030 |
Why?
|
Swine | 1 | 2005 | 5917 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1683 | 0.030 |
Why?
|
Femoral Artery | 1 | 2019 | 845 | 0.030 |
Why?
|
Urinalysis | 1 | 2016 | 369 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 194 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 13989 | 0.030 |
Why?
|
Bisoprolol | 1 | 2012 | 8 | 0.030 |
Why?
|
Transaminases | 1 | 2013 | 199 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13408 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 850 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2017 | 789 | 0.030 |
Why?
|
Language | 1 | 2022 | 1471 | 0.030 |
Why?
|
Resuscitation | 1 | 2017 | 658 | 0.030 |
Why?
|
Metoprolol | 1 | 2012 | 93 | 0.030 |
Why?
|
Bilirubin | 1 | 2013 | 425 | 0.030 |
Why?
|
Creatine | 1 | 2013 | 421 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2017 | 1462 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1738 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2016 | 1066 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 413 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1127 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2647 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5217 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2014 | 924 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 667 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2386 | 0.020 |
Why?
|
Norepinephrine | 1 | 2012 | 909 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3508 | 0.020 |
Why?
|
Endoscopy | 1 | 2019 | 1785 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 986 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3527 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2016 | 1224 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2065 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2540 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16718 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6489 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5078 | 0.020 |
Why?
|
Walking | 1 | 2013 | 1180 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4328 | 0.020 |
Why?
|
Respiration | 1 | 2012 | 1653 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5952 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Exercise Test | 1 | 2012 | 2074 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3341 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4933 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
Animals | 2 | 2006 | 168757 | 0.010 |
Why?
|
Medicaid | 1 | 2016 | 2736 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6309 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12720 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12951 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 12804 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5102 | 0.010 |
Why?
|